603882 金域醫學
按盤價 
42.850 +0.300 (+0.705%) | 2023/09 - 九個月 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.734 | 36.863 | 43.992 | 49.810 | 19.250 |
| 總資產報酬率 ROA (%) | 4.422 | 22.343 | 25.527 | 27.363 | 9.633 |
| 投入資產回報率 ROIC (%) | 6.207 | 33.432 | 38.736 | 31.906 | 14.484 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.441 | 43.128 | 47.292 | 46.685 | 39.476 |
| 營業利潤率 (%) | 10.182 | 21.628 | 23.250 | 22.039 | 9.186 |
| 息稅前利潤/營業總收入 (%) | 9.922 | 21.376 | 23.090 | 22.175 | 9.960 |
| 淨利潤/營業總收入 (%) | 8.981 | 18.370 | 19.790 | 19.086 | 7.881 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 117.022 | 106.417 | 101.367 | 100.216 | 87.378 |
| 價值變動淨收益/利潤總額(%) | 41.800 | -0.325 | -0.266 | -1.031 | 8.427 |
| 營業外收支淨額/利潤總額(%) | -2.432 | -0.798 | -1.063 | -0.353 | 2.358 | 償債能力分析 |
| 流動比率 (X) | 2.919 | 2.327 | 2.127 | 2.060 | 1.695 |
| 速動比率 (X) | 2.827 | 2.239 | 2.035 | 1.957 | 1.591 |
| 資產負債率 (%) | 28.663 | 36.110 | 39.330 | 41.612 | 47.089 |
| 帶息債務/全部投入資本 (%) | 4.609 | 4.748 | 7.664 | -- | 19.330 |
| 股東權益/帶息債務 (%) | 2,000.477 | 1,940.232 | 1,158.661 | 754.907 | 406.216 |
| 股東權益/負債合計 (%) | 243.121 | 172.083 | 149.086 | 137.082 | 109.905 |
| 利息保障倍數 (X) | -547.671 | -263.228 | 273.356 | 104.148 | 18.051 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 279.500 | 135.972 | 110.923 | 0.000 | 98.974 |
| 存貨周轉天數 (天) | 23.196 | 15.346 | 16.678 | 0.000 | 16.881 |
| 備註： | 即時報價更新時間為 25/04/2024 11:47 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
